|
Daehan New Pharm Announces Cash Dividend of 50 Won
2004.03.25
|
|---|
|
Daehan New Pharm Reappoints CEO Park Myung-rae; Elects Lee Cheon-soo as New Vice President and Choi Sung-sook as Auditor
Daehan New Pharm held its 20th regular shareholders' meeting at the Hyangnam Pharmaceutical Complex in Hwaseong, Gyeonggi Province, on the 22nd andd a cash dividend of 50 won (10%). At the meeting, incumbent CEO Park Myung-rae was reappointed, while Lee Cheon-soo was elected as the new director (Vice President), and Choi Sung-sook was elected as the new auditor.
Daehan New Pharm's annual sales for the previous year reached 37.823 billion KRW, marking an increase of 20.11% compared to the previous year. Operating profit increased by 8.54% to 2.566 billion KRW, while ordinary profit decreased by 8.35% to 1.986 billion KRW, and net profit decreased by 11.76% to 1.410 billion KRW.
CEO Park Myung-rae stated, "Daehan New Pharm is actively pursuing company-wide activities to discover new value-added businesses, alongside implementing innovation programs aimed at cost reduction and quality improvement of existing products. We will strive to achieve management performance that meets the expectations of our shareholders." |


Home